Enrique Grande

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Enrique Grande
Jan 19, 2025, 08:03 | Blog
Targetable mutations and tumor microenvironment in urachal cancer
Enrique Grande, Head of Oncology and an Adjunct Professor at the GU Medical Oncology Department at…
Jan 19, 2025, 04:45 | Insight
Enrique Grande: Adjuvant Radiation Following Cystectomy
Enrique Grande, Head of Oncology and an Adjunct Professor at the GU Medical Oncology Department…
Jan 15, 2025, 05:16 | Blog
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma
Enrique Grande shared on X: "Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal…
Jan 2, 2025, 15:38 | Insight
Final Overall Survival Analysis of S1500 on Advanced Papillary Renal Cell Carcinoma by Pedro Barata et al.
Enrique Grande, Head of Oncology at MD Anderson Cancer Center, shared a post on LinkedIn…
Dec 27, 2024, 04:28 | Blog
Enrique Grande: Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma
Enrique Grande, Associate Professor at Francisco de Vitoria University, shared on LinkedIn: “Real-World Outcomes in…
Dec 24, 2024, 23:31 | Science
Bladder-sparing Therapy for BCG-unresponsive Non-muscle-invasive Bladder Cancer
A recent paper by Roger Li, Urologic oncologist at Moffitt Cancer Center, was mentioned by…
Dec 23, 2024, 20:33 | Blog
Enrique Grande: When this time of year comes around we all look back and evaluate ourselves
Enrique Grande, Head of Oncology at MD Anderson Cancer Center, shared a post on LinkedIn: “I…
Dec 19, 2024, 16:41 | Blog
Survival after trimodal therapy in organ-confined bladder cancer
Enrique Grande, Associate Professor at Francisco de Vitoria University, shared an article by Mattia Longoni…
Dec 19, 2024, 14:08 | Blog
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Enrique Grande shared on X: "Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer…
Dec 17, 2024, 06:06 | Blog
Enrique Grande: NECTIN4 amplifications appear in ~25% of metastatic cases of urothelial carcinoma
Enrique Grande, Associate Professor at Francisco de Vitoria University, shared on LinkedIn: “New insights in…
Dec 13, 2024, 18:36 | Blog
The feasibility of a remote, personalized exercise program for patients on ICIs
Enrique Grande shared on LinkedIn: " Exercise + immunotherapy? This study shows the feasibility of a…
Dec 11, 2024, 19:07 | Blog
Reevaluating the role of platinum-based chemotherapy in the treatment landscape for advanced urothelial carcinoma
Enrique Grande shared on LinkedIn: "Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape…
Dec 7, 2024, 13:57 | Blog
Highlights from Day 1 of ESMO Asia 2024
ESMO Asia is an annual congress focused on multidisciplinary oncology in the Asian region. ESMO…
Dec 7, 2024, 01:50 | Blog
Enrique Grande: Honored to participate in ESMO Asia 2024 in Singapore
Enrique Grande, Associate Professor at Francisco de Vitoria University, posted on LinkedIn: "Honored to participate…
Dec 6, 2024, 11:01 | Blog
OncoInfluencers to Follow on Social Media: Dr. Enrique Grande
We’re excited to feature Dr. Enrique Grande, a distinguished leader in genitourinary and endocrine tumor…
Dec 5, 2024, 22:48 | Blog
Enrique Grande: FGFR inhibitors shaping the future of precision medicine
Enrique Grande, the Head of Oncology at MD Anderson Cancer Center Madrid, posted the following on…
Dec 5, 2024, 11:28 | Insight
Exercising and immuno-oncology treatment for patients with solid tumors
Enrique Grande shared a post on X: "Exercise + immunotherapy? This study shows the feasibility…
Nov 30, 2024, 23:26 | Blog
Enrique Grande: SITC Guideline on Immunotherapy for Urothelial Cancer
Enrique Grande, the Head of Oncology at MD Anderson Cancer Center Madrid, shared a post…
Nov 26, 2024, 17:35 | Blog
Enrique Grande: Couldn’t find a better host like Carolina Ibanez and a better partner in crime than Shilpa Gupta
Enrique Grande, the Head of Oncology at MD Anderson Cancer Center Madrid, shared a post…
Nov 25, 2024, 17:42 | Blog
Robot-assisted radical cystectomy vs open radical cystectomy for bladder cancer
Enrique Grande, Associate Professor at Francisco de Vitoria University, posted on X about recent paper…
Nov 21, 2024, 21:31 | Blog
Enrique Grande: Lucky to participate in the Annual Congress of the Spanish Group of Neuroendocrine Tumors
Enrique Grande, Head of Oncology at MD Anderson Cancer Center Madrid, shared a post on…
Nov 12, 2024, 16:41 | Insight
Enrique Grande: Pre-treatment metastatic biopsy by Niklas Klümper et al.
Enrique Grande, Head of Oncology at MD Anderson Cancer Center, shared a post on X…
Nov 8, 2024, 17:48 | Blog
Molecular Analysis of Renal Cell Carcinoma Sites
Enrique Grande, Head of Oncology at MD Anderson Cancer Center Madrid, shared an article by…
Oct 31, 2024, 15:47 | Blog
Enrique Grande: EVITA Criteria for Ineligibility in EV/Pembro for Metastatic Urothelial Cancer
Enrique Grande, Head of Oncology at MD Anderson Cancer Center Madrid, shared on LinkedIn: "…
Oct 18, 2024, 14:11 | Insight
Gut microbiome and bladder cancer: A new link through nitrosamine metabolism
Enrique Grande shared a post on LinkedIn: "Gut microbiome and bladder cancer: A new link…
Oct 14, 2024, 11:08 | Societies
Highlights from the LACOG Multidisciplinary GU Symposium 2024
The VIII International GU Review Symposium and the VI Multiprofessional Symposium took place from October…
Oct 11, 2024, 13:58 | Blog
Francesco Massari: Global real-world experience in mUC treatment
Francesco Massari, Medical Oncologist focused on Genitourinary Cancer at The University Hospital of Bologna IRCCS, posted…
Oct 5, 2024, 16:19 | Blog
Enrique Grande: How many challenges in GU tumors to try to address in the upcoming years?
Petros Grivas shared a post on X: "Adding a few recent Grivas Selfie examples for friends…
Sep 26, 2024, 16:11 | Blog
Chandler Park: Learning the latest cutting edge data to help our cancer patients at ESMO 24
Chandler Park shared a post on Linkedin: ''ESMO was FUN! Loved learning the latest cutting…
Sep 24, 2024, 08:41 | Blog
Joshua Hurwitz: Enrique Grande-a true pioneer in the field
Joshua Hurwitz shared a post on X: "A brilliant bladder cancer preceptorship at MD Anderson…
Sep 23, 2024, 15:40 | Insight
Olubukola Ayodele: Honored to take part in the Urothelial Cancer preceptorship by ACE Oncology
Olubukola Ayodele shared a post on LinkedIn: “It was truly an honor to have been…
Sep 22, 2024, 17:37 | Blog
Enrique Grande: Poor Outcomes for Basal/Squamous and Mixed Bladder Cancers in the VESPER Trial
Enrique Grande shared the following on LinkedIn: “Basal/squamous and Mixed subtype bladder cancers present poor…
Sep 22, 2024, 06:27 | Blog
Aruni Ghose: Closing the gap in Cervical Cancer
Aruni Ghose posted on LinkedIn: "As the London Global Cancer Week beckons 11th - 15th…
Sep 21, 2024, 14:04 | Blog
Enrique Grande: Another practice changing trial in the back
Enrique Grande shared a post on X: ''NIAGARA is the first randomized trial to demonstrate…
Sep 19, 2024, 14:05 | Blog
Yuksel Urun: The conference rooms are no longer enough for GU sessions at ESMO 24
Petros Grivas shared a post by Yuksel Urun on X: "Thrilled to co-chair GU session…
Sep 16, 2024, 16:31 | Societies
40 Posts Not To Miss From ESMO24 Day 3
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 16, 2024, 16:18 | Societies
Key Findings from the NIAGARA Trial at ESMO 2024
The results of the NIAGARA trial were recently presented at ESMO 2024. The NIAGARA trial,…
Sep 6, 2024, 17:48 | Insight
Enrique Grande: Honored to be appointed as Adjunct Professor at the GU Medical Oncology Department at the University of Texas MD Anderson Cancer Center
Enrique Grande shared a post by MD Anderson Madrid on X, adding: "I’m deeply honored…
Aug 18, 2024, 08:27 | Blog
Enrique Grande: Amazing review from Rana McKay and Neeraj Agarwal on the new PARPi + ARSIs combos
Enrique Grande posted on X about recent paper by Rana McKay et al., titled "First-line…
Aug 12, 2024, 22:11 | Blog
Enrique Grande: Acknowledging Grupo GETNE's contribution to neuroendocrine tumors
Enrique Grande shared on X: "Maybe we should stop one day to think and acknowledge the…
Aug 10, 2024, 13:59 | Insight
New hope in treating advanced grade 3 Neuroendocrine Neoplasms - Garcia-Carbonero's Lab
Garcia-Carbonero's Lab shared a post on X: “New hope in treating advanced grade 3 Neuroendocrine…
Aug 8, 2024, 18:34 | Insight
Molecular biomarkers of progression in non-muscle-invasive bladder cancer
Enrique Grande shared a paper by Mitchell Olislagers et al. on X, adding: “Molecular biomarkers…
Jul 25, 2024, 13:04 | Blog
Enrique Grande: Failure of Trials to Enhance Outcomes in mRCC Patients Re-challenged with Immunotherapy
Enrique Grande shared a post on X: "2 phase 3 trials have failed to improve…
Jul 19, 2024, 14:41 | Blog
DOR to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Enrique Grande shared a post on X: ''Durable Objective Response to Lurbinectedin in Small Cell…
Jul 10, 2024, 08:31 | Blog
ASCO - Why biomarkers are needed to optimize outcomes and avoid toxicities
ASCO shared on X: "Though novel therapies have improved survival in patients with mUC, many will…
Jul 6, 2024, 13:40 | Blog
Enrique Grande: Resistance to new drugs in bladder cancer
Enrique Grande shared a post on X: “Very happy to share our contribution to ASCO…
Jul 2, 2024, 11:31 | Blog
Challenges in non-muscle invasive bladder cancer by Ashish Kamat
Enrique Grande shared on X:          . "Brilliant talk about challenges in…
Jul 2, 2024, 11:12 | Blog
Enrique Grande: Fabulous and inspiring view of the short term future of advanced bladder cancer
Enrique Grande shared a post on X:                 …
Jun 26, 2024, 15:22 | Insight
Results from the NIAGARA Phase III trial
AztraZeneca released the results of the NIAGARA phase III trial, where INFINZI (durvalumab) showed EFS…
Jun 21, 2024, 05:08 | Insight
Enrique Grande: A Molecular-Directed Strategy with TP53 Mutation in small cell bladder cancer
Enrique Grande, Head of Oncology at MD Anderson Madrid Cancer Center, recently shared a post…
Jun 20, 2024, 14:10 | Insight
Enrique Grande: Epigenomic signatures of sarcomatoid differentiation of RCC
Enrique Grande shared a post on X: "On Cell Reports - Epigenomic signatures of sarcomatoid…
May 29, 2024, 09:04 | Societies
Shilpa Gupta: Glad to present our work on physician-reported 1L treatment patterns in 5 European countries
Enrique Grande, recently shared a post by Shilpa Gupta on X, adding: "We all always…
May 23, 2024, 11:26 | Drugs
Enrique Grande: Cabozantinib with or without PD-1/L1 inhibitors for metastatic clear cell renal cell carcinoma
Enrique Grande, Head of Oncology at MD Anderson Madrid Cancer Center, recently shared a post…
May 21, 2024, 12:45 | Insight
Enrique Grande: Improving antitumor immune response via Treg reduction in bladder cancer
Enrique Grande, Head of the Medical Oncology Service and Director of Clinical Research at the MD…
Apr 24, 2024, 14:45 | Blog
Regina Barragan-Carrillo: Great discussion on RCC management with Javier Molina Cerrillo!
Regina Barragan-Carrillo, Postdoctoral fellow at City of Hope, shared a post on X: "Great discussion on…
Jan 29, 2024, 17:38 | Insight
Roberto Iacovelli: The results of CABATEN study presented at GU24
Roberto Iacovelli, Associate Professor of Medical Oncology at Catholic University, Comprehensive Cancer Center of Rome,…
Jan 20, 2024, 17:47 | Blog
Roberto Iacovelli: Wonderful presentation from my friend Enrique Grande
Roberto Iacovelli, Associate Profesor of Medical Oncology at Catholic University, Comprehensive Cancer Center of Rome,…
Dec 12, 2023, 12:40 | Societies
20 Posts Not To Miss From ESMO Asia Congress 2023
The ESMO Asia Congress 2023 took place in Singapore from 1 to 3 December. Our…
All: 58 Posts: 1 - 100
Special Coverage